XML 118 R104.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings per share - Summary of earnings per share (Detail) - AUD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2018
Earnings per share [abstract]      
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (12,467) $ (10,270) $ (6,039)
Loss after income tax attributable to the owners of Kazia Therapeutics Limited $ (12,467) $ (10,270) $ (6,039)
Weighted average number of ordinary shares used in calculating basic earnings per share 73,053,514 57,503,555 48,376,525
Weighted average number of ordinary shares used in calculating diluted earnings per share 73,053,514 57,503,555 48,376,525
Basic earnings per share $ (17.07) $ (17.86) $ (12.48)
Diluted earnings per share $ (17.07) $ (17.86) $ (12.48)